Literature DB >> 6788570

Distinctive functional characteristics of human "T" lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody.

P C Beverley, R E Callard.   

Abstract

The properties of human lymphocyte fractions isolated either by sheep red cell(E) rosetting or by fluorescence-activated cell sorting after staining with UCHT1 monoclonal anti-T cell antibody have been compared. Two populations of E+ cells with very different phenotype and function have been identified. E+/UCHT1+ cells respond well to the T cell mitogens phytohemagglutinin and concanavalin A and provide help for an in vitro specific antibody response. They can also suppress the antibody response of allegeneic peripheral blood mononuclear cells. In contrast, the E+/UCHT1- population, which has no other markers characteristic of T cells, fails to respond to mitogens or to provide help or suppression for an antibody response. These cells, however, are highly active natural killers. They possess Fc gamma receptors and have a characteristic staining pattern of nonspecific esterase enzyme activity. It is concluded that not all cells capable of forming E rosettes are thymus-processed cells and that this heterogeneity can be revealed by staining with the monoclonal anti-T cell reagent UCHT1.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6788570     DOI: 10.1002/eji.1830110412

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  141 in total

1.  In vivo T-cell ablation by a holo-immunotoxin directed at human CD3.

Authors:  D M Neville; J Scharff; K Srinivasachar
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

2.  Characterization of two monoclonal antibodies (UCL4D12 and UCL3D3) that discriminate between human mantle zone and marginal zone B cells.

Authors:  J Smith-Ravin; J Spencer; P C Beverley; P G Isaacson
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

3.  A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.

Authors:  Uwe Reusch; Johannes Duell; Kristina Ellwanger; Carmen Herbrecht; Stefan Hj Knackmuss; Ivica Fucek; Markus Eser; Fionnuala McAleese; Vera Molkenthin; Fabrice Le Gall; Max Topp; Melvyn Little; Eugene A Zhukovsky
Journal:  MAbs       Date:  2015       Impact factor: 5.857

4.  Crystal structure of a human CD3-epsilon/delta dimer in complex with a UCHT1 single-chain antibody fragment.

Authors:  Kelly L Arnett; Stephen C Harrison; Don C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-08       Impact factor: 11.205

5.  Activation of peripheral blood lymphocytes in patients with primary Sjögren's syndrome.

Authors:  P Youinou; Y L Pennec; M A Blaschek; A Gentric; J Jouquan; A Lamour; P Angelidis
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

6.  Monoclonal antibodies specific for human monocytes, granulocytes and endothelium.

Authors:  N Hogg; S MacDonald; M Slusarenko; P C Beverley
Journal:  Immunology       Date:  1984-12       Impact factor: 7.397

7.  Nature of non-B, non-T lymphomas: an immunohistological study on frozen tissues using monoclonal antibodies.

Authors:  G Pallesen; P C Beverley; E B Lane; M Madsen; D Y Mason; H Stein
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

8.  Comparison of serum and synovial fluid concentrations of beta 2-microglobulin and C reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis.

Authors:  M T Walters; F K Stevenson; R Goswami; J L Smith; M I Cawley
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

9.  Ligand intercellular adhesion molecule 1 has a necessary role in activation of integrin lymphocyte function-associated molecule 1.

Authors:  C Cabañas; N Hogg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

10.  An immunohistological study of secondary Sjögren's syndrome.

Authors:  D A Isenberg; D Rowe; A Tookman; A Hopp; M Griffiths; E Paice; J Stewart; P C Beverley
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.